Leptin and uric acid as predictors of metabolic syndrome in jordanian adults

  • Obeidat, Ahmad A. (Department of Clinical Nutrition, Faculty of Applied Medical Sciences, Taibah University) ;
  • Ahmad, Mousa N. (Department of Nutrition, Faculty of Agriculture, University of Jordan) ;
  • Haddad, Fares H. (Department of Endocrinology, King Hussein Medical Center) ;
  • Azzeh, Firas S. (Department of Clinical Nutrition, Faculty of Applied Medical Sciences, Umm Al-Qura University)
  • Received : 2015.10.27
  • Accepted : 2016.01.19
  • Published : 2016.08.01


BACKGROUND/OBJECTIVES: Metabolic syndrome (MetS) is a set of interrelated metabolic risk factors that increase the risk of cardiovascular morbidity and mortality. Studies regarding the specificity and sensitivity of serum levels of leptin and uric acid as predictors of MetS are limited. The aim of this study was to evaluate the serum levels of leptin and uric acid in terms of their specificity and sensitivity as predictors of MetS in the studied Jordanian group. SUBJECTS/METHODS: In this cross sectional study, 630 adult subjects (308 men and 322 women) were recruited from the King Hussein Medical Center (Amman, Jordan). The diagnosis of MetS was made according to the 2005 International Diabetes Federation criteria. Receiver operating characteristic curves were used to determine the efficacy of serum levels of leptin and uric acid as predictors of MetS in the studied Jordanian group. RESULTS: Study results showed that for identification of subjects with MetS risk, area under the curve (AUC) for leptin was 0.721 and 0.683 in men and women, respectively. Serum uric acid levels in men showed no significant association with any MetS risk factors and no significant AUC, while uric acid AUC was 0.706 in women. CONCLUSION: Serum leptin levels can be useful biomarkers for evaluation of the risk of MetS independent of baseline obesity in both men and women. On the other hand, serum uric acid levels predicted the risk of MetS only in women.


  1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
  2. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, Gaye A, Gogele M, Heier M, Hiekkalinna T, Joensuu A, Newby C, Pang C, Partinen E, Reischl E, Schwienbacher C, Tammesoo ML, Swertz MA, Burton P, Ferretti V, Fortier I, Giepmans L, Harris JR, Hillege HL, Holmen J, Jula A, Kootstra-Ros JE, Kvaloy K, Holmen TL, Mannisto S, Metspalu A, Midthjell K, Murtagh MJ, Peters A, Pramstaller PP, Saaristo T, Salomaa V, Stolk RP, Uusitupa M, van der Harst P, van der Klauw MM, Waldenberger M, Perola M, Wolffenbuttel BH. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord 2014;14:9-22.
  3. Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome-from insulin resistance to obesity and diabetes. Endocrinol Metab Clin North Am 2008;37:559-79.
  4. Romao I, Roth J. Genetic and environmental interactions in obesity and type 2 diabetes. J Am Diet Assoc 2008;108:S24-8.
  5. World Health Organization (WHO). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Geneva: World Health Organization; 1999.
  6. Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diabet Med 2010;27:593-7.
  7. Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol 2013;62:697-703.
  8. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011;378:804-14.
  9. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012:1-8.
  10. Manjunath D, Uthappa CK, Kattula SR, Allam RR, Chava N, Oruganti G. Metabolic syndrome among urban Indian young adults: prevalence and associated risk factors. Metab Syndr Relat Disord 2014;12:381-9.
  11. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-81.
  12. Chuengsamarn S, Rattanamongkoulgul S, Villarroel A. Association between metabolic syndrome and risk of cardiovascular disease, using different criteria and stratified by sex. Int J Diabetes Mellit 2010;2:78-82.
  13. van Beek EA, Bakker AH, Kruyt PM, Hofker MH, Saris WH, Keijer J. Intra- and interindividual variation in gene expression in human adipose tissue. Pflugers Arch 2007;453:851-61.
  14. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010;152:93-100.
  15. Ozcelik E, Uslu S, Kebapci N, Kara M, Dokumacioglu A, Musmul A. Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome. Diabetes Metab Syndr 2010;4:13-7.
  16. Yun JE, Kimm H, Jo J, Jee SH. Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations. Metabolism 2010;59:424-9.
  17. Bjorntorp P. Hypertension and the Metabolic Syndrome: closely related central origin? Int Congr Ser 2002;1241:81-6.
  18. Ukkola O, Kesaniemi YA. Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects. Metabolism 2007;56:1221-7.
  19. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008;52:1201-10.
  20. Thorand B, Zierer A, Baumert J, Meisinger C, Herder C, Koenig W. Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg study 1984-2002. Diabet Med 2010;27:1004-11.
  21. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N; WOSCOPS Executive Committee. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001;104:3052-6.
  22. Li WC, Hsiao KY, Chen IC, Chang YC, Wang SH, Wu KH. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults. Cardiovasc Diabetol 2011;10:36-42.
  23. Ingelsson E, Larson MG, Yin X, Wang TJ, Meigs JB, Lipinska I, Benjamin EJ, Keaney JF Jr, Vasan RS. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J Clin Endocrinol Metab 2008;93:3149-57.
  24. Numata T, Miyatake N, Wada J, Makino H. Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. Diabetes Res Clin Pract 2008;80:e1-5.
  25. de Oliveira EP, Burini RC. High plasma uric acid concentration:causes and consequences. Diabetol Metab Syndr 2012;4:12-9.
  26. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006;290:F625-31.
  27. Lee MS, Lin SC, Chang HY, Lyu LC, Tsai KS, Pan WH. High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr 2005;14:285-92.
  28. Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007;115:2526-32.
  29. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008;57:845-52.
  30. Chiou WK, Wang MH, Huang DH, Chiu HT, Lee YJ, Lin JD. The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J Epidemiol 2010;20:219-24.
  31. Liu M, He Y, Jiang B, Wu L, Yang S, Wang Y, Li X. Association between serum uric acid level and metabolic syndrome and its sex difference in a chinese community elderly population. Int J Endocrinol 2014:754678.
  32. Billiet L, Doaty S, Katz JD, Velasquez MT. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 2014:852954.
  33. Sheikhbahaei S, Fotouhi A, Hafezi-Nejad N, Nakhjavani M, Esteghamati A. Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes. Metab Syndr Relat Disord 2014;12:102-9.
  34. Lin JD, Chiou WK, Chang HY, Liu FH, Weng HF. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. Metabolism 2007;56:751-6.
  35. Liu PW, Chang TY, Chen JD. Serum uric acid and metabolic syndrome in Taiwanese adults. Metabolism 2010;59:802-7.
  36. Longo-Mbenza B, Mvindu HN, Phanzu BK, On'Kin JB, Nkakudulu Bikuku H, Nge Okwe A. Is uric acid a surrogate and additional component of incident metabolic syndrome, insulin resistance among inactive Central Africans? Diabetes Metab Syndr 2010;4:74-81.
  37. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:943162.
  38. Obeidat AA, Ahmad MN, Haddad FH, Azzeh FS. Evaluation of several anthropometric indices of obesity as predictors of metabolic syndrome in Jordanian adults. Nutr Hosp 2015;32:667-77.
  39. Ajlouni K, Jaddou H, Batieha A. Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors. J Intern Med 1998;244:317-23.
  40. Centers for Disease Control and Prevention (CDC). Prevalence of selected risk factors for chronic disease--Jordan, 2002. MMWR Morb Mortal Wkly Rep 2003;52:1042-4.
  41. Centers for Disease Control and Prevention (CDC). Assessing risk factors for chronic disease--Jordan, 2004. MMWR Morb Mortal Wkly Rep 2006;55:653-5.
  42. Hammoudeh AJ, Al-Tarawneh H, Elharassis A, Haddad J, Mahadeen Z, Badran N, Izraiq M, Al-Mousa E. Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS). Int J Cardiol 2006;110:179-83.
  43. Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence of the metabolic syndrome among Northern Jordanians. J Diabetes Complications 2007;21:214-9.
  44. Al-Odat AZ, Ahmad MN, Haddad FH. References of anthropometric indices of central obesity and metabolic syndrome in Jordanian men and women. Diabetes Metab Syndr 2012;6:15-21.
  45. Obeidat BA, Al-Shami EK, Abdul-Razzak KK, Khader YS. Predictors of metabolic syndrome among employees: a study from Jordan. Food Nutr Sci 2012;3:669-77.
  46. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [Internet]. Brussels: International Diabetes Federation Communications; 2006 March 19 [cited 2014 October 11]. Available from:
  47. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: anthropometry and physical activity monitor procedures manual [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2005 January 1 [cited 2014 October 11]. Available from: nhanes_05_06/BM.pdf.
  48. Lee RD, Nieman DC. Nutritional Assessment. 5th ed. New York (NY): McGraw-Hill Education; 2010.
  49. Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005;54:1914-25.
  50. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007;96:644-7.
  51. Canatan H, Bakan I, Akbulut M, Baydas G, Halifeoglu I, Gursu MF. Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects. Endocr Res 2004;30:95-105.
  52. Lyoussi B, Ragala MA, Mguil M, Chraibi A, Israili ZH. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans. Clin Exp Hypertens 2005;27:377-94.
  53. Hamed M. Haddad SH, AL Quobili F. Serum uric acid and leptin levels in metabolic syndrome. Int J Pharm Sci Rev Res 2013;20:21-7.
  54. Correia ML, Haynes WG. Obesity-related hypertension: is there a role for selective leptin resistance? Curr Hypertens Rep 2004;6:230-5.
  55. Lee CY, Lee CH, Tsai S, Huang CT, Wu MT, Tai SY, Lin FF, Chao NC, Chang CJ. Association between serum leptin and adiponectin levels with risk of insulin resistance and impaired glucose tolerance in non-diabetic women. Kaohsiung J Med Sci 2009;25:116-25.
  56. Zhuo Q, Wang Z, Fu P, Piao J, Tian Y, Xu J, Yang X. Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 2009;84:27-33.
  57. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2005;183:147-55.
  58. Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J 2004;148:635-40.
  59. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, Levesque S, Varga S. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004;93:159-64.
  60. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005;69:928-33.
  61. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005;25:1038-44.
  62. Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD, Song GG. Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. Metabolism 2008;57:71-6.